ArticleDigestive diseases and sciences2026
Prognostic Utility of Systemic Inflammatory Response Syndrome (SIRS) Criteria in Acute Alcohol-Associated Hepatitis.
Article in Digestive diseases and sciences, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
16 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
objectivesAcute alcohol-associated hepatitis (AAH) is a severe inflammatory liver condition with high morbidity and mortality. Many patients with AAH exhibit features of the Systemic Inflammatory Response Syndrome (SIRS). While Maddrey's Discriminant Function (MDF) and Model for End-Stage Liver Disease (MELD) are established tools used to assess severity and guide treatment, the prognostic utility of SIRS criteria remains unclear. We hypothesized that AAH patients with more SIRS criteria would show greater illness severity, reduced steroid responsiveness, and worse 30-day survival.
methodsRetrospective analysis was conducted on 531 AAH patients hospitalized between 2012 and 2019. Patients were stratified into ≥ 2 SIRS criteria (n = 243) and < 2 criteria (n = 288). Demographics, laboratory parameters, and scoring system measures (MDF, MELD) were collected. The primary outcome was 30-day (30-d) survival. Secondary outcomes were disease severity (MELD) and response to steroids.
resultsThe mean age was 47; the majority were male (56%) and White (66%). Several baseline characteristics differed between groups. Patients with ≥ 2 SIRS criteria had significantly lower albumin (2.86 vs 2.97 g/dL, p = 0.035), higher MDF (40.1 vs 36.1, p = 0.004), higher admission MELD scores (20.9 vs 20.1, p = 0.04), and similar response to steroids (68% vs 64%). Thirty-day survival was numerically lower in the ≥ 2 SIRS group (86.9%) vs the < 2 group (91.5%) (p = 0.18), suggesting a trend toward worse outcomes with higher SIRS burden.
conclusionHigher SIRS criteria are associated with greater disease severity, similar biochemical and prognostic scoring abnormalities, as well as a non-significant trend toward worse 30-day survival. Further prospective studies are warranted to clarify prognostic value of SIRS, guide treatment and risk stratification in AAH.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.